Showing results (21-30 of 185) with videos related to
Sort By:
Pageof 19
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 1, 1990
Ondansetron (GR38032) in the prophylaxis of acute and delayed cisplatin-induced emesisF Roila, S Bracarda, M Tonato, et al.European Journal of Clinical Pharmacology|January 1, 1990
Assessment of nauseaA Del Favero, F Roila, C Basurto, et al.Pharmacoeconomics|February 7, 1994
Cost and cost-effectiveness analysis of ondansetron versus metoclopramide regimens: a hospital perspective from ItalyE Ballatori, F Roila, P Berto, et al.American Journal of Clinical Oncology|April 1, 1992
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patientsF Roila, S Bracarda, C Basurto, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
OndansetronF Roila, M Tonato, C Basurto, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesisF Roila, C Basurto, S Bracarda, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Reliability and validity of a quality of life questionnaire in cancer patientsE Ballatori, F Roila, C Basurto, et al.Infection|November 1, 1986
Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazoleF Menichetti, A Del Favero, R Guerciolini, et al.Tumori|October 31, 1985
Evaluation of the antiemetic activity of bromopride in cancer patients treated with i.v. CMFF Roila, V Minotti, E Ballatori, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
A phase II antiemetic combination (COMD) for cisplatin-induced nausea and vomitingF Roila, C Basurto, V Minotti, et al.Pageof 19